Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2008 · 4.9K citations · Full text

Veterinary Medicine, Infectious Diseases, Oncology +7

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson et al. · New England Journal of Medicine · 2002 · 3.3K citations · Full text

Life Sciences, Microbiology, Pharmacology +10

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

Thomas J. Walsh, Elias Anaissie, David W. Denning et al. · Clinical Infectious Diseases · 2008 · 2.7K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

Kieren A. Marr, Rachel A. Carter, Michael Boeckh et al. · Blood · 2002 · 953 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

J. Maertens, Issam Raad, G. Petrikkos et al. · Clinical Infectious Diseases · 2004 · 662 citations · Full text

Medicine, Microbiology, Pharmacology +17